slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,33 CNY | +3,54% | +2,43% | -39,05% |
26/04 | Walvax Biotechnology's winst daalt met 92%, bedrijfsinkomen daalt met 28% in Q1 2024 | MT |
25/04 | Eenheid van Walvax Biotechnology stopt met proeven met COVID-19-vaccins | MT |
Omzet 2024 * | 4,13 mld. 570 mln. 533 mln. | Omzet 2025 * | 5,36 mld. 740 mln. 692 mln. | Marktkapitalisatie | 22,92 mld. 3,16 mld. 2,96 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 781 mln. 108 mln. 101 mln. | Nettowinst (verlies) 2025 * | 1,12 mld. 155 mln. 145 mln. | EV/omzet 2024 * | 4,54 x |
Nettoliquiditeiten 2024 * | 4,17 mld. 575 mln. 538 mln. | Nettoliquiditeiten 2025 * | 4,77 mld. 658 mln. 615 mln. | EV/omzet 2025 * | 3,38 x |
K/w-verhouding 2024 * |
29,2
x | K/w-verhouding 2025 * |
20,6
x | Werknemers | 2.388 |
Dividendrendement 2024 * |
0,7% | Dividendrendement 2025 * |
0,84% | Vrij verhandelbaar | 27,42% |
1 dag | +3,54% | ||
1 week | +2,43% | ||
Lopende maand | -6,83% | ||
1 maand | -10,77% | ||
3 maanden | -22,54% | ||
6 maanden | -34,51% | ||
Lopend jaar | -39,05% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Run Sheng Jiang
PSD | President | 67 | 22-06-16 |
Hua Zhou
DFI | Director of Finance/CFO | 57 | 23-06-14 |
Shao zhong Dong
BRD | Director/Board Member | 56 | 27-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Zhen Huang
BRD | Director/Board Member | 61 | 01-01-03 |
Yun Chun Li
CHM | Chairman | 62 | 23-06-09 |
Jin Yu Zhu
BRD | Director/Board Member | 57 | 23-06-09 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 14,33 | +3,54% | 24 848 250 |
25-04-24 | 13,84 | -2,12% | 26 536 100 |
24-04-24 | 14,14 | -0,77% | 13 425 930 |
23-04-24 | 14,25 | -0,28% | 14 354 610 |
22-04-24 | 14,29 | +2,14% | 14 827 800 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-39,05% | 3,16 mld. | |
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
-9,14% | 11,95 mld. | |
+5,24% | 8,71 mld. | |
-8,42% | 8,12 mld. |